A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis

Journal of Family Practice

Volumn 47, Issue 2, 1998, Pages 118-125

  Ratner, Paul H ^a   Van Bavel, Julius H ^b   Martin, Bruce G ^d   Hampel Jr , Frank C ^e   Howland III, William C ^c   Rogenes, Paula R ^f   Westlund, Ronald E ^f   Bowers, Brian W ^f   Cook, Cindy K ^f  

^a Sylvana Research   (United States)

^b Austin Allergy Associates   (United States)

^c HealthQuest Research   (United States)

^d SW Allerg and Asthma Res Center ^*  (United States)

^e Central Texas Health Research   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Allergic; Antihistamine; Fluticasone propionate aqueous nasal spray; Loratadine; Rhinitis; Seasonal

Indexed keywords

FLUTICASONE; LORATADINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EPISTAXIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; MALE; MIDDLE AGED; POLLEN; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; TEXAS;

EID: 0031821502     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bousquet J, Dhivert H, Michel F-B. Current trends in the management of allergic diseases. Allergy 1994; 94:31-6.
2. Horak F. Seasonal allergic rhinitis. Newer treatment approaches. Drugs 1993; 45:518-27.
3. Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Beclomethasone dipropionate. H. Allergic rhinitis and other conditions. Drugs 1975; 10:211-38.
4. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84(suppl A):19-23.
5. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84(suppl A):25-29.
6. Howland WC III, Hampel FC Jr., Martin BG, Ratner PH, van Bavel JH, Field EA. The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects. Clin Ther 1996; 18:1106-17.
7. Howland WC III. Fluticasone propionate: topical or systemic effects? Clin Exp Allergy 1996; 26(suppl 3):18-22.
8. Nayak AS, Shulan D, Bernstein DI, et al. Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for treatment of seasonal allergic rhinitis symptoms [abstract 63]. J Allergy Clin Immunol 1996; 97:198.
9. Ramsdale HE, Kline PA. Comparison of once daily treatment with an antihistamine (loratadine) and topical steroid (fluticasone propionate) during the ragweed pollen season [abstract 636]. J Allergy Clin Immunol 1991; 87(suppl):298.
10. Gehanno P, Desfougeres JL. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy 1997; 52:445-50.
11. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:588-95.
12. van Bavel J, Findlay S, Hampel F, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994; 154:2699-2704.
13. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994; 24:1144-50.
14. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqeuous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:915-21.
15. Stricker WE, Klimas JT, Mendelson L, et al. Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis [abstract P34]. Ann Allergy 1994; 72:86.
16. Vervloet D, Charpin D, Desfougeres J-L. Intranasal fluticasone once daily compared with once-daily cetirizine in the treatment of seasonal allergic rhinitis. Clin Drug Invest 1997; 13:291-8.
17. Drouin MA, Yang WH, Horak F, et al. Is there a benefit to adding loratadine to topical nasal steroids in patients with moderately severe seasonal allergic rhinoconjunctivitis? [abstract]. Allergy 1992; 12(suppl):173.
18. Wihl JA, Nuchel Petersen B, Nuchel Peterson L, et al. Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 1985; 75:720-7.
19. Jarmoszuk I, LeFach J, Hogan A. Dual therapy for seasonal allergic rhinitis (SAR) with terfenadine (T) and beclomethasone nasal aerosol (B) [abstract]. J Allergy Clin Immunol 1986; 77(suppl):138.
20. Benincasa C, Lloyd RS. Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest 1994; 8:225-33.
21. Linder A. Symptom scores as measures of the severity of rhinitis. Clin Allergy 1988; 18:29-37.
22. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
23. Cox FM, Bowers BW, Ratner PH, Cook CK, Westlund R, Rogenes PR. The effect of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, on pharmacoeconomic outcomes in patients with seasonal allergic rhinitis. J Managed Care Pharm. In press.
24. Olsen OT, Nüchel Petersen LN, Høi L, Lorentzen KA, Hindberg Rasmussen W, Svendsen UG. Comparison of loratadine and terfenadine in allergic seasonal rhinoconjunctivitis with emphasis on nasal stuffiness and peak flow. Arzneimittelforschung 1992; 42:1227-31.
25. Mackowiak JI. Fluticasone propionate aqueous nasal spray (FP) improves rhinitis quality of life and reduces lost labor costs [abstract P86]. Ann Allergy 1994; 72:99.
26. Lemanske R, Dunn K, Galant S, et al. Fluticasone propionate aqueous nasal spray is more effective than astemizole in the treatment of seasonal allergic rhinitis [abstract 15]. J Allergy Clin Immunol 1994; 93:165.
27. Bousquet J. Clinical activity and side effects of loratadine and astemizole in patients with seasonal allergic rhinitis [abstract]. Presented at the 44th Annual Congress of the American College of Allergists; Boston, Mass, November 1987.
28. Oei HD. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Ann Allergy 1988; 61:436-9.
29. Del Carpio J, Kabbash L, Turenne Y, et al. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84:741-6.
30. Horak F, Bruttmann G, Pedrali P, et al. A multicentre study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneimittelforschung 1988; 38:124-8.
31. Meltzer EO, Schatz M. Pharmacotherapy of rhinitis: 1987 and beyond. Immunol Allergy Clin North Am 1987; 7:57-91.
32. Brompton Hospital/Medical Research Council Collaborative Trial. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in the treatment of perennial rhinitis for twelve months. Clin Allergy 1980; 10:239-51.
33. Schenkel EJ, Nolop R, Mesarina-Wicki B. Evaluation of mometasone furoate (NasonexTM) nasal spray with the addition of loratadine vs a placebo in the treatment of seasonal allergic rhinitis [abstract]. Presented at the American College of Allergy, Asthma and Immunology 1996 Annual Meeting, Boston, Mass, November 8-13, 1996.
34. Nathan RA, Bronsky EA, Firemen P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991; 67:332-8.